Megan Ranney, MD, dean of the Yale School of Public Health, said PopHIVE is funded through both foundation and individual philanthropic donations, and has no federal funding. The PopHIVE team is ...
A 26-year FDA scientist and administrator, Pazdur has headed the agency's Oncology Center of Excellence since its creation in ...
Recommendations for optimal gestational weight gain are different depending on a woman's body mass index (BMI), ranging from ...
This third of five exclusive episodes explores how clinicians can navigate newly approved MASH therapies -- resmetirom (Rezdiffra) and semaglutide (Wegovy) -- and how to tailor treatment choices based ...
Hormone therapy is an effective treatment for vasomotor symptoms but is contraindicated for some women, including breast cancer patients. Self-administered hypnosis demonstrated a significant edge ...
President Donald Trump has pardoned Tennessee Republican Rep. Diana Harshbarger's husband, who pleaded guilty more than a ...
NEW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection ...
The investigational Bruton's tyrosine kinase inhibitor fenebrutinib reduced annualized relapse rates versus teriflunomide ...
Personalized vitamin D supplementation -- often requiring 5,000 IU of vitamin D each day -- did prove to have secondary ...
Invasive lobular carcinoma accounts for about 10% of breast cancer diagnoses. Its incidence is increasing at the rate of 2.8% annually -- more than triple that of other breast cancers combined. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback